AI assistant
Milestone Pharmaceuticals Inc. — Director's Dealing 2019
May 8, 2019
9643_dirs_2019-05-08_232ca533-bb09-4d6b-9807-058bee94e680.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Milestone Pharmaceuticals Inc. (MIST)
CIK: 0001408443
Period of Report: 2019-05-08
Reporting Person: Plat Francis (Chief Medical Officer)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Shares | 11456 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Employee Stock Option (right to buy) | $0.72 | 2024-12-18 | Common Shares (26076) | Direct | |
| Employee Stock Option (right to buy) | $0.72 | 2024-07-25 | Common Shares (5040) | Direct | |
| Employee Stock Option (right to buy) | $1.12 | 2025-08-26 | Common Shares (19729) | Direct | |
| Employee Stock Option (right to buy) | $1.54 | 2027-07-21 | Common Shares (83501) | Direct | |
| Employee Stock Option (right to buy) | $1.54 | 2028-10-15 | Common Shares (53202) | Direct | |
| Employee Stock Option (right to buy) | $2.66 | 2028-11-20 | Common Shares (37598) | Direct |
Footnotes
F1: Fully vested.
F2: The option grant has an exercise price of $0.96 Canadian Dollars. This represents the exercise price in United States Dollars.
F3: Twenty-five percent (25%) of the shares subject to the option vested on August 26, 2016, and one thirty-sixth (1/36th) of the remaining shares subject to the option vested or shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date.
F4: Twenty-five percent (25%) of the shares subject to the option vested on July 21, 2018, and one thirty-sixth (1/36th) of the remaining shares subject to the option vested or shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date.
F5: Twenty-five percent (25%) of the shares subject to the option shall vest on October 15, 2019, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date.
F6: Twenty-five percent (25%) of the shares subject to the option shall vest on November 21, 2019, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date.